Review
Endotoxin and Mammalian Host Responses During Experimental Disease

https://doi.org/10.1016/j.jcpa.2006.09.001Get rights and content

Summary

Endotoxin is an integral component of the outer membrane of Gram-negative bacteria and a prime example of unique and highly conserved bacterial surface molecules that engage with the innate immune system of the mammalian host via pattern recognition receptors on a range of host cells. The results of this interaction, which may be beneficial or detrimental to the development and welfare of the host, are reviewed, focusing on the different sensitivities and consequences in a range of hosts of experimental exposure to endotoxin, the disease outcomes and recent developments in our understanding of the mechanisms involved.

Introduction

The term endotoxin, credited to Pfeiffer 1904 (Westphal, 1984) was introduced to distinguish heat-stable toxin released during bacterial lysis from secreted, heat-labile bacterial exotoxins. In pure chemical form endotoxin is a lipopolysaccharide (LPS) (Rietschel et al., 1990), which has a widely variable composition (or chemotype) and exerts a wide range of often opposing influences on host–pathogen interactions. It is an integral component of the outer membrane of Gram-negative bacteria, essential for viability (Poxton and Edmond, 1995); it should be mentioned, however, that a slow-growing mutant of Neisseria meningitidis lacking any detectable LPS was reported by Steeghs et al. (1998). LPS is also a major bacterial virulence factor (Burns and Hull, 1998; Pollack, 1999) and a prime example of highly conserved bacterial molecular patterns, including lipoteichoic acids and flagellin, that occur primarily on the surface of pathogens (Pugin et al., 1994; Krug et al., 2001; Seya et al., 2001) and engage with the innate immune system via pattern recognition receptors (Janssens and Beyaert, 2003). Variation in LPS structure can also contribute to the avoidance of immune detection through molecular mimicry of host structures. Examples of this include mimicry of gangliosides by Campylobacter jejuni and of Lewis antigens by Helicobacter pylori (Moran and Prendergast, 2001). Pattern recognition receptors (PRRs) of the mammalian innate immune system include Toll-like receptors (TLRs) (Beutler and Poltorak, 2000; Bowie and O’Neill, 2000; Brightbill and Modlin, 2000; Means et al., 2000; Modlin, 2002), a novel group of transmembrane receptors that are the mammalian equivalent of Toll receptors described originally for the fruit fly (Rock et al., 1998). Bacterial molecular patterns have been considered mainly in the context of recognized pathogens—hence the common collective term “pathogen-associated molecular patterns” (PAMPs); however, they also occur in commensal bacteria, in which they have been termed CAMPs (Cario et al., 2002). Because the boundaries between pathogenic organisms and those considered harmless become indistinct in the light of disease caused by environmental bacteria (see below), the more general term microbial-associated molecular patterns (MAMPs) will be used in this review. At least 10 mammalian TLRs have been identified to date, including a receptor for LPS (TLR4), and an understanding of the associated binding and signalling processes may lead to better means of preventing or controlling bacterial disease and avoiding autoimmune type diseases. This review, after a brief summary of the well-documented structure and overall biological effects of endotoxin, will focus on (1) the consequences of experimental exposure of a range of hosts to endotoxin, (2) the pathological outcomes, and (3) recent developments in our understanding of the mechanisms.

Section snippets

Composition, Structure and Function of Endotoxin

The various chemotypes of LPS form a collection of heterogeneous glycoconjugates (Nowotny, 1990) consisting of O-antigen, outer and inner core polysaccharides, and covalently bound lipid (“lipid A”) (Rietschel et al., 1990). There are many authoritative reviews of the composition and structure of endotoxin (Rietschel et al., 1994, Rietschel et al., 1993, Rietschel et al., 1991; Raetz, 1993; Seydel et al., 1993; Moran, 1995; Schromm et al., 1998; Morrison et al., 1999; El Samalouti et al., 2000;

Mechanisms of Host–Endotoxin Interaction

In addition to its interaction with TLRs (see below), endotoxin interacts with the host via a range of receptors and intermediates, including soluble ligands such as high-density lipoprotein, surface-bound and soluble CD14, LBP (Kitchens, 2005), bactericidal/permeability-increasing protein (BPI), antimicrobial peptides (Werling et al., 1996; Vreugdenhil et al., 1999; Wu et al., 2004; Hari-Dass et al., 2005) and the leucocyte integrin CD18 (Paape et al., 1996).

The effects of exposure of host

Outcome of Exposure of the Host to Endotoxin

Reactions to endotoxin administered in crude or purified form have been well-described, although not necessarily backed up by serum analyses to enable endotoxin concentrations to be correlated with observed effects. There are many reports of the effects of LPS on rodents but few (Khan et al., 1998) of naturally occurring LPS-related disease in these animals.

Administration of endotoxin in vivo has been used commonly in the study of cellular and molecular host responses, to increase understanding

Measurement of Endotoxin in Biological Fluids

A common method of endotoxin measurement is based on the initiation of the coagulation cascade in LAL by LPS (Tanaka and Iwanaga, 1993). However, it is notoriously difficult to obtain a reliable and repeatable estimate of endotoxin in plasma or serum samples; this is because the reaction of endotoxin with LAL is susceptible to either inhibition or enhancement due to contaminants such as fungal beta glucans (Hausmann et al., 2000) or factors present in blood. It was observed (Hodgson,

Opposing Effects of Endotoxin

The sequence of reactions initiated by macrophage–LPS interactions may be detrimental or beneficial by contributing to the pathogenesis of disease or to the priming of host defence mechanisms, respectively. Detrimental effects include fever, hypotension, multiple organ failure, and death (Vincent, 1996); beneficial effects include polyclonal antibody induction, adjuvancy, normal development of lymphoid organs, and macrophage activation (Gollahon et al., 1983; Vogel and Hogan, 1990). Much

Endotoxin-related Diseases

Endotoxin is a key aetiological agent in a range of important animal and human diseases, including systemic colibacillosis in sheep and cattle (Hodgson, 1994), salmonellosis in a range of animals (Fierer and Guiney, 2001), systemic pasteurellosis in sheep caused by Pasteurella trehalosi (Hodgson et al., 1993) and septic shock in man (Barron, 1993). Additionally, endotoxin is implicated in bowel oedema in pigs (Beers-Schreurs et al., 1992) and Reye's syndrome in children (Cooperstock et al., 1975

Other Models of Shock and What we have Learnt of Mechanisms

The range of animal models used to study sepsis highlights the difficulty of devising an acceptable experimental approach. Ideally, a model should be (1) characterized by biochemical and physiological changes similar to those in the natural disease, (2) reproducible, (3) as humane as possible, and (4) an accurate predictor of the results of clinical trials of new therapeutic agents. Associated requirements for such a model include use of bacterial phenotypes that evade host defences and doses

Variation in Sensitivity to LPS Shown at Different Stages of Physiological Development and by Different Animal Species

Pulmonary injury is induced by minute amounts (a few micrograms or nanograms) of bacterial endotoxin in sheep, calves, pigs and cats, but not in laboratory animals or dogs (Winkler, 1988). The relatively low sensitivity of mice to LPS varies with their genetic make-up; thus, for example, C3H/HeJ mice, in which the gene controlling LPS responsiveness is defective, are resistant to the effects of endotoxin (Heumann et al., 1996). Hormonal responses, for example growth hormone response, appear to

Concluding Remarks

Just as in the past the discovery of the role of cytokines, chemokines and eicosanoids as mediators of the effects of LPS re-focussed endotoxin research, so now does the current interest in TLRs. The demonstration of different TLRs for different PAMPs (Krug et al., 2001) should enable us to target specific pathogens or pathogenic effects and avoid “blunderbuss” approaches with the attendant danger of side-effects or indiscriminate damage to host tissues and processes. Ultimately, the concept of

Acknowledgments

Thanks are due to Ms H Simm for help with Fig. 3, Fig. 4, Fig. 5a–c and to Drs K. Angus, D. Buxton and M. P. Dagleish for help and advice with Fig. 5. Research on this topic is supported by the Scottish Executive Environment Rural Affairs Department.

References (232)

  • L. Hamann et al.

    Components of gut bacteria as immunomodulators

    International Journal of Food Microbiology

    (1998)
  • L.A. Hansen et al.

    Endotoxin potency in the A549 lung epithelial cell bioassay and the Limulus amebocyte lysate assay

    Journal of Immunological Methods

    (1999)
  • R. Hari-Dass et al.

    Serum amyloid A protein binds to outer membrane protein A of Gram-negative bacteria

    Journal of Biological Chemistry

    (2005)
  • D. Hersh et al.

    How bacteria initiate inflammation: aspects of the emerging story

    Current Opinion in Microbiology

    (1998)
  • D. Heumann et al.

    Molecular basis of host-pathogen interaction in septic shock

    Current Opinion in Microbiology

    (1998)
  • J.C. Hodgson et al.

    Prophylactic use of human endotoxin-core hyperimmune gamma-globulin to prevent endotoxemia in colostrum-deprived, gnotobiotic lambs challenged orally with Escherichia coli FEMS

    Immunology and Medical Microbiology

    (1995)
  • J.C. Hodgson et al.

    Effects of interactions between Pasteurella haemolytica and Bordetella parapertussis on in vitro phagocytosis by lung macrophages

    Biologicals

    (1996)
  • J.C. Hodgson et al.

    Biochemical and haematological evidence of endotoxic shock in gnotobiotic lambs with watery mouth-disease

    Research in Veterinary Science

    (1989)
  • J.C. Hodgson et al.

    Host responses during infection in newborn lambs

    FEMS Microbiology Immunology

    (1989)
  • A. Horadagoda et al.

    Immediate responses in serum TNFα and acute phase protein concentrations to infection with Pasteurella haemolytica A1 in calves

    Research in Veterinary Science

    (1994)
  • N.U. Horadagoda et al.

    Role of endotoxin in the pathogenesis of haemorrhagic septicaemia in the buffalo

    Microbial Pathogenesis

    (2001)
  • N.U. Horadagoda et al.

    Development of a clinical syndrome resembling haemorrhagic septicaemia in the buffalo following intravenous inoculation of Pasteurella multocida serotype B:2 endotoxin and the role of tumour necrosis factor-alpha

    Research in Veterinary Science

    (2002)
  • R.R. Ingalls et al.

    Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors

    Infectious Disease Clinics of North America

    (1999)
  • G.E. Jones et al.

    Protection of lambs against experimental pneumonic pasteurellosis by transfer of immune serum

    Veterinary Microbiology

    (1989)
  • T.L. Kielian et al.

    CD14 and other recognition molecules for lipopolysaccharide—a review

    Immunopharmacology

    (1995)
  • A.M. Krieg

    Immune effects and mechanisms of action of CpG motifs

    Vaccine

    (2000)
  • A.M. Krieg

    Now I know my CpGs

    Trends in Microbiology

    (2001)
  • R.L. Lafleur et al.

    Lipopolysaccharide enhances cytolysis and inflammatory cytokine induction in bovine alveolar macrophages exposed to Pasteurella (Mannheimia) haemolytica leukotoxin

    Microbial Pathogenesis

    (2001)
  • A.M. Abdelnoor

    Effect of LPS on the clotting system

  • C. Alexander et al.

    Bacterial lipopolysaccharides and innate immunity

    Journal of Endotoxin Research

    (2001)
  • L.A. Babiuk et al.

    Viral-bacterial synergistic interactions/pathogenesis in cattle

  • R.L. Barron

    Pathophysiology of septic shock and implications for therapy

    Clinical Pharmacy

    (1993)
  • M.H. Barton et al.

    Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease

    Journal of Veterinary Internal Medicine

    (1999)
  • K. Bauermeister et al.

    Distinct regulation of IL-8 and MCP-1 by LPS and interferon-gamma-treated human peritoneal macrophages

    Nephrology, Dialysis, Transplantation

    (1998)
  • H.M. Beers-Schreurs et al.

    The pathogenesis of the post-weaning syndrome in weaned piglets: a review

    Veterinary Quarterly

    (1992)
  • B. Beutler et al.

    Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response

    Endocrine Reviews

    (1988)
  • B. Beutler et al.

    Cachectin (tumor necrosis factor): an endogenous mediator of shock and inflammatory response

  • B. Beutler et al.

    Positional cloning of LPS, and the general role of toll-like receptors in the innate immune response

    European Cytokine Networks

    (2000)
  • B. Beutler et al.

    The sole gateway to endotoxin response: how LPS was identified as TLR4, and its role in innate immunity

    Drug Metabolism and Disposition

    (2001)
  • J. Blood-Siegfried

    Sudden infant death syndrome: a toxic response

    American Association of Critical-Care Nurses Clinical Issues

    (2000)
  • L.V. Borovikova et al.

    Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

    Nature

    (2000)
  • G.D. Bottoms et al.

    Involvement of prostaglandins and leukotrienes in the pathogenesis of endotoxemia and sepsis

    Journal of the American Veterinary Medical Association

    (1992)
  • A. Bowie et al.

    The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products

    Journal of Leukocyte Biology

    (2000)
  • S.G. Bradley

    Interactions between endotoxin and protein synthesis

  • P. Brandtzaeg et al.

    Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

    Journal of Infectious Diseases

    (1989)
  • N. Briard et al.

    IGF-I/IGFBPs system response to endotoxin challenge in sheep

    Journal of Endocrinology

    (2000)
  • H.D. Brightbill et al.

    Review article: toll-like receptors: molecular mechanisms of the mammalian immune response

    Immunology

    (2000)
  • K.A. Brogden et al.

    Pasteurella haemolytica lipopolysaccharide-associated protein induces pulmonary inflammation after bronchoscopic deposition in calves and sheep

    Infection and Immunity

    (1995)
  • K.A. Brogden et al.

    Serologic examination of the Westphal-type lipopolysaccharides of Pasteurella multocida

    American Journal of Veterinary Research

    (1978)
  • S.M. Burns et al.

    Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5

    Infection and Immunity

    (1998)
  • Cited by (0)

    View full text